Enliven Therapeutics director Garland J. Scott disposes of $606,719 in common shares

Bitget2026/10/05 20:57

Director Garland J. Scott exercised stock options for 13,000 Enliven Therapeutics common shares on Oct. 1, 2026 at USD 15.47. He sold 13,000 shares the same day at a weighted average price of USD 46.6707. His directly held common stock position fell to 0 shares following the transactions. Scott reported 46,372 stock options held following the exercise. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001533228-26-000009), on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.